Breaking News
Healthcare
Investing News
Market News
The Market Buzz
Breaking News: Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute
Mydecine Innovations Group Inc. (OTC: MYCOF) (CSE: MYCO), is pleased to announce that, further to its press release of July 14, 2020, its prospective acquisition target NeuroPharm Inc. (“NeuroPharm”),...